Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersInternal Medicine Physician in Lake Worth, FL
NPI: 1245693597Primary Practice Location
HCA FLORIDA JFK HOSPITAL
5301 S Congress Ave, Atlantis, FL
Primary Employer
HHA Hospital Medicine
myhospit.ipower.com
HQ Phone
Get M.D. PH.D Jing's Phone NumberMobile
Get M.D. PH.D Jing's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2019 - 2027
American Board of Internal Medicine
Internal Medicine
One Brooklyn Health System - Kingsbrook Jewish Medical Center
Residency • Internal Medicine
2016 - 2019
Sun Yat-Sen University of Medical Science
Medical School
Until 2007
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 208 | 535 |
| 2 | 99239Hospital discharge day management, more than 30 minutes | 193 | 202 |
| 3 | 99497Advance care planning by the physician or other qualified health care professional | 146 | 149 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 71 | 72 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 13 | 38 |
Using human genetics to improve safety assessment of therapeutics.
Authors: Carss, Keren J, Deaton, Aimee M, Del Rio-Espinola, Alberto, Diogo, Dorothée, Fielden, Mark, Kulkarni, Diptee A, Moggs, Jonathan, Newham, Peter, Nelson, Matthew R, Sistare, Frank D, Ward, Lucas D, Yuan, Jing
Journal: Nat Rev Drug Discov
Publication Date: 2022-10-19
Design and Discovery of N-(2-Methyl-5′-morpholino-6′-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3′-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers
Authors: Gisele Nishiguchi, Alice Rico, Huw Tanner, Robert J. Aversa, Benjamin R. Taft, Sharadha Subramanian, Lina Setti, Matthew Burger, Lifeng Wan, Victoriano Tamez, Aaron Smith, Yan Lou, Paul A. Barsanti, Brent A. Appleton, Mulugeta Mamo, Laura Tandeske, Ina Dix, John Tellew, Shenlin Huang, Lesley A. Mathews Griner, Vesselina G. Cooke, Anne Van Abbema, Hanne Merritt, Sylvia Ma, Kalyani Gampa, Fei Feng, Jing Yuan, Yingyun Wang, Jacob R. Haling, Sepideh Vaziri, Mohammad Hekmat-Nejad, Johanna M. Jansen, Valery Polyakov, Richard Zang, Vijay Sethuraman, Payman Amiri, Mallika Singh, Emma Lees, Wenlin Shao, Darrin Stuart, Michael Patrick Dillon, Savithri Ramurthy
Publication Date: 2017-06
Authors: Korpal, Manav, Korn, Joshua M, Gao, Xueliang, Rakiec, Daniel P, Ruddy, David A, Doshi, Shivang, Yuan, Jing, Kovats, Steve G, Kim, Sunkyu, Cooke, Vesselina G, Monahan, John E, Stegmeier, Frank, Roberts, Thomas M, Sellers, William R, Zhou, Wenlai, Zhu, Ping
Journal: Cancer Discov
Publication Date: 2013-07-10
